BuzzSparks.org

PolyTherics


PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing...

Founded in 2001
Homepage:
Total money raised: $32.5M

NW1 0TU The London Bioscience Innovation Centre
2 Royal College Street

London
GBR

Phone: 44-(0)207-691-4928

Updated on Nov 22, 2013
PolyTherics at CrunchBase
Ken Cunningham Executive Chairman
Matthew Baker Chief Scientific Officer
John Burt Chief Executive Officer
Sally Waterman Chief Operating Officer
Stephane Mery Non-Executive Director
Past

July, 2013

PolyTherics raised $21.4M in unattributed round from Imperial Innovations, Invesco Perpetual, and Mercia Fund Management

U.K. biotech PolyTherics scores $20.1M in funding for Antitope merger Read more: U.K. biotech PolyTherics scores $20.1M in funding for Antitope merger - FierceBiotech http://www.fiercebiotech.com/story/uk-biotech-polytherics-scores-201m-funding-antitope-    fiercebiotech.com

September, 2011

PolyTherics raised $3.4M in unattributed round from Imperial Innovations

Imperial Innovations Leads GBP2.15M Round For PolyTherics    fis.dowjones.com

April, 2010

PolyTherics raised $4M in a Series C round from Imperial Innovations, Longbow Capital, and The Capital Fund

PolyTherics, Ltd.: Series C $4M    onbiovc.com

June, 2007

PolyTherics raised $3.6M in unattributed round from Longbow Capital and Imperial Innovations

Innovative Biopharmaceutical Company, PolyTherics, raises over £2 million    polytherics.co.uk

2001

PolyTherics was founded in 2001